Bexarotene (Targretin®)
D0228
Phase 1 small_molecule completed
Quick answer
Bexarotene (Targretin®) for Advanced, Malignant Aerodigestive Tract Tumor (Lung, Head and Neck and Esophagus) is a Phase 1 program (small_molecule) at LIGAND PHARMACEUTICALS INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- LIGAND PHARMACEUTICALS INC
- Indication
- Advanced, Malignant Aerodigestive Tract Tumor (Lung, Head and Neck and Esophagus)
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed